Lemborexant, a Dual Orexin Receptor Antagonist, ameliorates Tau‐mediated Sleep Loss and Neurodegeneration

Alzheimer s & Dementia
December 1, 2024
Cited by 1


Related Papers

No related papers found

Powered by citation graph analysis